99 results
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
26 Apr 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
6 Mar 24
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
4:21pm
8-K
EX-10.2
ADIL
Adial Pharmaceuticals Inc
18 Jan 24
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
4:15pm
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
6 Nov 23
Departure of Directors or Certain Officers
6:14am
8-K
EX-10.1
ADIL
Adial Pharmaceuticals Inc
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-10.2
pvabnx
24 Oct 23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:48pm
8-K
EX-10.1
v5re snjjvno
2 Jun 23
Entry into a Material Definitive Agreement
6:02am
8-K
EX-10.1
twpiylm5fnjygjawi
21 Mar 23
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder
9:15am
8-K
EX-10.3
dpmzra ts
24 Feb 23
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
9:00am
8-K
EX-10.2
ooutig718 nj
24 Feb 23
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
9:00am
8-K
EX-10.1
ztuhs jb26f
24 Feb 23
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
9:00am
8-K
EX-10.1
oovb kwdvsqo
1 Feb 23
Adial Pharmaceuticals Enters Into Option Agreement
4:13pm
8-K
EX-10.1
07r2s9phd 7ossg
13 Oct 22
Departure of Directors or Certain Officers
4:56pm
8-K
EX-10.1
9c7ngrz 6sv7r7
13 Sep 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.1
bg7ixm5ne2
23 Aug 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.2
5s6qjdbmm i6f
23 Aug 22
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.1
0kolgd
14 Feb 22
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering
5:11pm
8-K
EX-10.2
azqnfdh
14 Feb 22
Adial Pharmaceuticals Announces Pricing of $10 Million Registered Direct Offering
5:11pm
8-K
EX-10.1
b4yxndn 5f
9 Dec 21
Adial Announces Cary J. Claiborne, a Renowned Pharmaceutical Executive and Current Board Member, has Joined the Company as Chief Operating Officer
9:29am